{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:55:07Z","timestamp":1787849707821,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.brainres.2011.09.016","type":"journal-article","created":{"date-parts":[[2011,9,18]],"date-time":"2011-09-18T23:10:21Z","timestamp":1316387421000},"page":"110-120","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats"],"prefix":"10.1016","volume":"1421","author":[{"given":"Koji","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Horita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Takaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.brainres.2011.09.016_bb0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2003.11.049","article-title":"Perirhinal N-methyl-d-aspartate and muscarinic systems participate in object recognition in rats","volume":"356","author":"Abe","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2011.09.016_bb0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0006-8993(89)90095-4","article-title":"Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro","volume":"491","author":"Barnes","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2011.09.016_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0006-8993(90)90294-L","article-title":"Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition","volume":"507","author":"Barnes","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2011.09.016_bb0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yhbeh.2006.03.016","article-title":"Angiotensin II disrupts inhibitory avoidance memory retrieval","volume":"50","author":"Bonini","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.brainres.2011.09.016_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0026-895X(25)14945-6","article-title":"Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422","volume":"25","author":"Cascieri","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainres.2011.09.016_bb0030","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198606263142602","article-title":"The effects of antihypertensive therapy on the quality of life","volume":"314","author":"Croog","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.brainres.2011.09.016_bb0035","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias","author":"Davies","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.brainres.2011.09.016_bb0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-8993(02)02695-1","article-title":"The effect of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion","volume":"947","author":"de Wilde","year":"2002","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.brainres.2011.09.016_bb0045","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1096\/fj.11-182873","article-title":"Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease","volume":"25","author":"Dong","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.brainres.2011.09.016_bb0050","doi-asserted-by":"crossref","first-page":"30471","DOI":"10.1074\/jbc.M605827200","article-title":"Regulation of steady-state \u03b2-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme","volume":"281","author":"Eckman","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2011.09.016_bb0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jnnp.2006.104034","article-title":"The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration","volume":"78","author":"Ellul","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2011.09.016_bb0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-4328(89)80051-8","article-title":"A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam","volume":"33","author":"Ennaceur","year":"1989","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2011.09.016_bb0065","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainresrev.2007.01.003","article-title":"Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases","volume":"54","author":"Farkas","year":"2007","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2011.09.016_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/14779072.3.1.15","article-title":"Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril","volume":"3","author":"Ferrari","year":"2005","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.brainres.2011.09.016_bb0075","first-page":"197","article-title":"Angiotensin II-inhibiting drugs have no effect on intraneuronal A\u03b2 or oligomeric A\u03b2 levels in a triple transgenic mouse model of Alzheimer's disease","volume":"3","author":"Ferrington","year":"2011","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.brainres.2011.09.016_bb0080","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1471-4159.1980.tb09011.x","article-title":"Elevation of substance P-like immunoreactivity in rat central nervous system by protease inhibitors","volume":"35","author":"Hanson","year":"1980","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.brainres.2011.09.016_bb0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1054\/npep.2000.0824","article-title":"Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery","volume":"34","author":"Hasen\u00f6hrl","year":"2000","journal-title":"Neuropeptides"},{"issue":"7","key":"10.1016\/j.brainres.2011.09.016_bb0090","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1212\/01.wnl.0000238102.04582.ec","article-title":"ACE activity in CSF of patients with mild cognitive impairment and Alzheimer disease","volume":"67","author":"He","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2011.09.016_bb0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.nbd.2007.01.004","article-title":"Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease","volume":"26","author":"Hemming","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"22","key":"10.1016\/j.brainres.2011.09.016_bb0100","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1097\/00029330-200811020-00019","article-title":"Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease","volume":"121","author":"Hou","year":"2008","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.brainres.2011.09.016_bb0105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nlm.2006.08.010","article-title":"Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats","volume":"87","author":"Jenkins","year":"2007","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.brainres.2011.09.016_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2010.03.038","article-title":"Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus","volume":"636","author":"Ji","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2011.09.016_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1570-0232(03)00250-2","article-title":"Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography\u2013mass spectrometry","volume":"791","author":"Kerns","year":"2003","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.brainres.2011.09.016_bb0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-004-2074-5","article-title":"Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism","volume":"179","author":"Kerr","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.brainres.2011.09.016_bb0125","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.31.3.780","article-title":"Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men","volume":"31","author":"Kilander","year":"1998","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.brainres.2011.09.016_bb0130","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1460-9568.2000.00942.x","article-title":"Facilitation of cholinergic transmission by substance P methyl ester in the mouse hippocampal slice preparation","volume":"12","author":"Kouznetsova","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.brainres.2011.09.016_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1254\/jjp.53.201","article-title":"Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities","volume":"53","author":"Kubo","year":"1990","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.brainres.2011.09.016_bb0140","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuroscience.2008.06.023","article-title":"Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats","volume":"155","author":"Kumaran","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2011.09.016_bb0145","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.brainres.2011.09.016_bb0150","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1021\/jm0100990","article-title":"ElogDoct: a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds","volume":"44","author":"Lombardo","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2011.09.016_bb0155","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-8993(02)04211-7","article-title":"Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats","volume":"966","author":"Manschot","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2011.09.016_bb0160","first-page":"163","article-title":"Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes","volume":"1","author":"Miners","year":"2009","journal-title":"Am. J. Transl. Res."},{"issue":"7","key":"10.1016\/j.brainres.2011.09.016_bb0165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3109\/10641969909052199","article-title":"Evaluation of high through-to-peak ratio of perindopril in SHR","volume":"21","author":"Moriyama","year":"1999","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.brainres.2011.09.016_bb0170","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2011.09.016_bb0175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF02244598","article-title":"Reinforcing effects of peripherally administered substance P and its C-terminal sequence pGlu6-SP6-11 in the rat","volume":"100","author":"Oitzl","year":"1990","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.brainres.2011.09.016_bb0180","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/gps.1523","article-title":"Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment","volume":"21","author":"Rozzini","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.brainres.2011.09.016_bb0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-510X(02)00302-7","article-title":"Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models","volume":"203\u2013204","author":"Sarti","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"13","key":"10.1016\/j.brainres.2011.09.016_bb0190","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Centrally active ACE inhibitors may slow cognitive decline: the cardiovascular health study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.brainres.2011.09.016_bb0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0196-9781(84)90020-2","article-title":"Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase","volume":"5","author":"Skidgel","year":"1984","journal-title":"Peptides"},{"issue":"13","key":"10.1016\/j.brainres.2011.09.016_bb0200","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1097\/00001756-199609020-00034","article-title":"Release of cerebral acetylcholine increases during visually mediated behavior in monkeys","volume":"7","author":"Tang","year":"1996","journal-title":"Neuroreport"},{"issue":"23","key":"10.1016\/j.brainres.2011.09.016_bb0205","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.94.23.12667","article-title":"Effects of muscarinic blockade in perirhinal cortex during visual recognition","volume":"94","author":"Tang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainres.2011.09.016_bb0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-4328(97)86058-5","article-title":"Facilitation of memory by peripheral administration of substance P","volume":"83","author":"Tomaz","year":"1997","journal-title":"Behav. Brain Res."},{"issue":"9","key":"10.1016\/j.brainres.2011.09.016_bb0215","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.53.9.1948","article-title":"Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging","volume":"53","author":"Tzourio","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2011.09.016_bb0220","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch. Intern. Med."},{"issue":"3\u20134","key":"10.1016\/j.brainres.2011.09.016_bb0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ddr.430140324","article-title":"Hoe 288: indications on the memory-enhancing effects of a peptidase inhibitor","volume":"14","author":"Usinger","year":"1988","journal-title":"Drug Dev. Res."},{"issue":"4","key":"10.1016\/j.brainres.2011.09.016_bb0230","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1212\/01.wnl.0000341271.90478.8e","article-title":"Vascular risk factors and dementia: how to move forward?","volume":"72","author":"Viswanathan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2011.09.016_bb0235","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/jnr.22237","article-title":"Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion","volume":"88","author":"Wang","year":"2010","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.brainres.2011.09.016_bb0240","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0896-6273(03)00358-1","article-title":"Cholinergic neurotransmission is essential for perirhinal cortical plasticity and recognition memory","volume":"38","author":"Warburton","year":"2003","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.brainres.2011.09.016_bb0245","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1460-9568.2005.04055.x","article-title":"Removal of cholinergic input to perirhinal cortex disrupts object recognition but not spatial working memory in the rat","volume":"21","author":"Winters","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2011.09.016_bb0250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1081\/CEH-120024988","article-title":"Age-related decline in spatial learning and memory: attenuation by captopril","volume":"25","author":"Wyss","year":"2003","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.brainres.2011.09.016_bb0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","article-title":"Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease","volume":"1352","author":"Yamada","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2011.09.016_bb0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.clpt.6100483","article-title":"The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women","volume":"84","author":"Yasar","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2011.09.016_bb0265","doi-asserted-by":"crossref","first-page":"31914","DOI":"10.1074\/jbc.M109.011437","article-title":"Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme","volume":"284","author":"Zou","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899311017197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899311017197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:25:50Z","timestamp":1741710350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899311017197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":53,"alternative-id":["S0006899311017197"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2011.09.016","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}